Clinical Trials Logo
  1. Home
  2. Non-Hodgkin's Lymphoma (NHL)
  3. NCT01108341

Study to Evaluate the Efficacy and Safety of Treatment With Bendamustine in Combination With Ofatumumab in Previously Untreated Patients With Indolent B-Cell Non-Hodgkin's Lymphoma (NHL)

Non-Hodgkin's Lymphoma (NHL) Clinical Trial

Official title:
An Open-Label Study to Evaluate the Efficacy and Safety of Treatment With Bendamustine in Combination With Ofatumumab in Previously Untreated Patients With Indolent B-Cell Non-Hodgkin's Lymphoma (NHL)

Clinical Trial Summary

The primary objective of the study is to determine the efficacy, as measured by overall response (complete response + partial response) of bendamustine in combination with ofatumumab in previously untreated patients with indolent B-Cell Non-Hodgkin's Lymphoma (NHL).

Clinical Trial Description

n/a

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01108341
Study type Interventional
Source Teva Pharmaceutical Industries
Contact
Status Completed
Phase Phase 2
Start date May 2010
Completion date October 2011
View Details
See also
  Status Clinical Trial Phase
Completed NCT01448928 - Zevalin Post-marketing Surveillance in Japan
Terminated NCT00089284 - Phase I/II Trial of Redox Regulation in Patients With Relapsed or Refractory CD20+ NHL Phase 1/Phase 2
Unknown status NCT01983761 - Study of ASC-101 in Patients With Hematologic Malignancies Who Receive Dual-cord Umbilical Cord Blood Transplantation Phase 1/Phase 2
Recruiting NCT01758042 - Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders N/A
Terminated NCT00185679 - Haploid Allogeneic Transplant Using the CliniMACS System Phase 2
Completed NCT00129090 - Mega-CHOEP: Conventional Chemo Vs HD Chemo Followed by Auto SCT in Younger Pts With Aggressive Non-Hodgkin's Lymphoma Phase 3
Completed NCT01527838 - Single Treatment With FT1050 of an Ex-vivo Modulated Umbilical Cord Blood Unit Phase 1
Completed NCT00923910 - Wilm's Tumor 1 Protein Vaccine to Treat Cancers of the Blood Phase 1/Phase 2
Completed NCT00614042 - Phase 1/1b Study of TRU-016 in Patients With Previously Treated CLL or Select Subtypes of Non-Hodgkin's Lymphoma Phase 1
Completed NCT02071888 - Study of the Glutaminase Inhibitor CB-839 in Hematological Tumors Phase 1
Recruiting NCT04696705 - Allogeneic γδ T Cells Immunotherapy in r/r Non-Hodgkin's Lymphoma (NHL) or Peripheral T Cell Lymphomas (PTCL) Patients Early Phase 1
Completed NCT01479387 - Zevalin Post-marketing Surveillance for Adequateness of Image Interpretation Criteria in Japan N/A
Completed NCT00889798 - Tumor Registry of Lymphatic Neoplasia
Terminated NCT05144347 - Study of XL114 in Subjects With Non-Hodgkin's Lymphoma Phase 1